跳至主要内容
临床试验/NCT06207253
NCT06207253招募中2 期

The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament During Root Canal Treatment: A Randomized Clinical Trial

British University In Egypt1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2025年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
48
试验地点
1
主要终点
Bacterial count

研究概览

简要总结

The goal of this randomized clinical trial is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials are used as intracanal medications in permanent molar teeth with chronic apical periodontitis.

The main question[s] it aims to answer are:

• Will the diclofenac sodium (NSAIDs) possess antimicrobial efficacy to be used effectively as an intracanal medicament similar to that of calcium hydroxide in primary endodontic treatment? Participants will be allocated randomly into three equal groups by using computer generated randomization, according to the type of intracanal medication.

详细描述

The aim of the present study is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials are used as intracanal medications in permanent molar teeth with chronic apical periodontitis. The evaluation is to be done using quantitative microbiological assessment from samples extracted from root canals before and after intracanal medicament placement in roots of permanent molars, having PAI score ≥ 2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with teeth diagnosed with apical periodontitis
  • Periapical Index (PAI) ≥ 2
  • The teeth are restorable

排除标准

  • Teeth with immature roots
  • Non restorable teeth
  • Medically compromised patients with systemic complication that would alter the treatment.
  • Teeth with internal/external root resorption
  • Patient with an allergy to diclofenac sodium

研究组 & 干预措施

High concentration of diclofenac sodium

Experimental

High concentration of diclofenac sodium mixed with saline

干预措施: Diclofenac Sodium (Drug)

Low concentration of diclofenac sodium

Active Comparator

Low concentration of diclofenac sodium mixed with saline

干预措施: Diclofenac Sodium (Drug)

Calcium hydroxide

Active Comparator

Calcium hydroxide paste form

干预措施: Calcium hydroxide (Drug)

结局指标

主要结局

Bacterial count

时间窗: On the seventh day from of intracanal medication placement appointment

Variation in bacterial count in high concentration of Diclofenac Sodium group compared by group of low concentration of Diclofenac Sodium group and calcium hydroxide group.

次要结局

  • incidence and intensity of pain(Pain intensity will be assessed at 24 hours, 48 hours and 72 hours following initial treatment using a visual analogue scale)
  • Periapical healing(participants will be recalled after 6 months from the obturation for radiographic examination.)
  • Incidence of flare-ups(Presence of flare-ups will be recorded each day after the intracanal medication placement visit till the next visit (after seven days).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Summer Elsayed

Principle Investigator

British University In Egypt

研究点 (1)

Loading locations...

相似试验

The Antimicrobial Potential of Diclofenac Sodium as... | 临床试验